141 related articles for article (PubMed ID: 8217281)
1. [Suramin activity in human head and neck squamous cell carcinoma cell lines].
Li AT
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(2):108-9, 125. PubMed ID: 8217281
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
Kalli KR; Bradley SV; Fuchshuber S; Conover CA
Gynecol Oncol; 2004 Sep; 94(3):705-12. PubMed ID: 15350362
[TBL] [Abstract][Full Text] [Related]
3. [Effects of suramin on cell proliferation of various types of human malignant cells].
Bai LY; Miyazaki M; Namba M
Gan To Kagaku Ryoho; 1991 Mar; 18(3):387-91. PubMed ID: 1848419
[TBL] [Abstract][Full Text] [Related]
4. Suramin inhibits growth factor binding and proliferation by urothelial carcinoma cell cultures.
Gansler T; Vaghmar N; Olson JJ; Graham SD
J Urol; 1992 Sep; 148(3):910-4. PubMed ID: 1512858
[TBL] [Abstract][Full Text] [Related]
5. Effect of suramin on squamous differentiation and apoptosis in three human non-small-cell lung cancer cell lines.
Lokshin A; Levitt ML
J Cell Biochem Suppl; 1996; 24():186-97. PubMed ID: 8806101
[TBL] [Abstract][Full Text] [Related]
6. [The enhancement of the chemotherapeutic effects on human prostate cancer cell--the combination with the growth factor interaction inhibitor (suramin)].
Suzuki Y; Miwa Y; Akino H; Fujita T; Saikawa S; Kanimoto Y; Okada K
Hinyokika Kiyo; 1993 Dec; 39(12):1215-20. PubMed ID: 8285172
[TBL] [Abstract][Full Text] [Related]
7. Influence of epidermal growth factor receptor expression on the cetuximab and panitumumab response rates of head and neck carcinoma cells.
Hartmann S; Seher A; Brands RC; Linz C; Lessner G; Böhm H; Kübler AC; Müller-Richter UD
J Craniomaxillofac Surg; 2014 Oct; 42(7):1322-8. PubMed ID: 24780353
[TBL] [Abstract][Full Text] [Related]
8. The effect of schedule, protein binding and growth factors on the activity of suramin.
Lopez Lopez R; Peters GJ; van Loenen AC; Pizao PE; van Rijswijk RE; Wagstaff J; Pinedo HM
Int J Cancer; 1992 Jul; 51(6):921-6. PubMed ID: 1639540
[TBL] [Abstract][Full Text] [Related]
9. Effects of antiepidermal growth factor receptor antibody 528 on the proliferation and differentiation of head and neck cancer.
Sturgis EM; Sacks PG; Masui H; Mendelsohn J; Schantz SP
Otolaryngol Head Neck Surg; 1994 Nov; 111(5):633-43. PubMed ID: 7970803
[TBL] [Abstract][Full Text] [Related]
10. [The effect of suramin on human lung cancer cell line in vitro].
Fujiuchi S; Tsuji T; Ohsaki Y; Kikuchi K
Gan To Kagaku Ryoho; 1994 Apr; 21(5):647-52. PubMed ID: 8154891
[TBL] [Abstract][Full Text] [Related]
11. Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines.
Scher RL; Saito W; Dodge RK; Richtsmeier WJ; Fine RL
Otolaryngol Head Neck Surg; 1998 Apr; 118(4):464-71. PubMed ID: 9560096
[TBL] [Abstract][Full Text] [Related]
12. Effect of suramin on human esophageal cancer cells in vitro and in vivo.
Shin R; Naomoto Y; Kamikawa Y; Tanaka N; Orita K
Scand J Gastroenterol; 1997 Aug; 32(8):824-8. PubMed ID: 9282976
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of epidermal growth factor receptor signaling decreases p63 expression in head and neck squamous carcinoma cells.
Matheny KE; Barbieri CE; Sniezek JC; Arteaga CL; Pietenpol JA
Laryngoscope; 2003 Jun; 113(6):936-9. PubMed ID: 12782800
[TBL] [Abstract][Full Text] [Related]
14. Suramin inhibits the growth of non-small-cell lung cancer cells that express the epidermal growth factor receptor.
Fujiuchi S; Ohsaki Y; Kikuchi K
Oncology; 1997; 54(2):134-40. PubMed ID: 9075785
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop.
Schrell UM; Gauer S; Kiesewetter F; Bickel A; Hren J; Adams EF; Fahlbusch R
J Neurosurg; 1995 Apr; 82(4):600-7. PubMed ID: 7897522
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of growth stimulation by suramin in non-small-cell lung cancer cell lines.
Lokshin A; Peng X; Campbell PG; Barsouk A; Levitt ML
Cancer Chemother Pharmacol; 1999; 43(4):341-7. PubMed ID: 10071987
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of Nafamostat mesilate on head and neck squamous cell carcinoma.
Yamashita Y; Ishiguro Y; Sano D; Kimura M; Fujita K; Yoshida T; Horiuchi C; Taguchi T; Matsuda H; Mikami Y; Tsukuda M
Auris Nasus Larynx; 2007 Dec; 34(4):487-91. PubMed ID: 17337140
[TBL] [Abstract][Full Text] [Related]
18. Suramin interferes with auto/paracrine insulin-like growth factor I-controlled proliferative loop on human lung cancer cell lines.
Favoni RE; Ravera F; Pirani P; Ardizzoni A; Noonan D; de Cupis A
Eur J Pharmacol; 1994 Oct; 264(2):199-206. PubMed ID: 7851483
[TBL] [Abstract][Full Text] [Related]
19. Surface membrane-expressed CD40 is present on tumor cells from squamous cell cancer of the head and neck in vitro and in vivo and regulates cell growth in tumor cell lines.
Posner MR; Cavacini LA; Upton MP; Tillman KC; Gornstein ER; Norris CM
Clin Cancer Res; 1999 Aug; 5(8):2261-70. PubMed ID: 10473114
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic actions of suramin on the proliferation of human breast-cancer cells in vitro.
Foekens JA; Sieuwerts AM; Stuurman-Smeets EM; Dorssers LC; Berns EM; Klijn JG
Int J Cancer; 1992 May; 51(3):439-44. PubMed ID: 1592534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
